Results-focused biomedical engineer and manager of healthcare market research & analytics with over 10 years of experience in the medical sciences and particular focus on drug delivery systems, tissue engineering, cardiovascular medical devices and biopharmaceuticals. Currently supporting new product initiatives, industry partnerships, clinical trial development and company growth through strategic planning, competitive intelligence and technology review. My analysis has been featured in the New York Times, Wall Street Journal, Forbes, Thomson Reuters, Becker's Spine, Diagnostic & Interventional Cardiology, and Modern Healthcare, amongst others.

Manager, Market Research & Analytics @ Juniper Pharmaceuticals is a Boston, MA and Nottingham, UK based specialty biotechnology platform company focused on the development of novel therapeutics for diseases and conditions lacking effective treatment using proprietary drug delivery systems. Juniper's market cap has grown 150% since I joined, from $62M to over $155M. As the company's Manager of Market Research & Analytics I am responsible for a number of cross-departmental activities, including: • evaluating disease states & the competitive drug/device landscape • financial modeling of new product and lifecycle management opportunities • conducting due diligence on emerging technologies & potential partnerships • composing strategic plans & market reviews for new drug advancement • supporting intellectual property & patent licensing • fielding external correspondences exploring potential new product commercialization initiatives • researching and developing new product initiatives • reporting drug market activity and tracking new sales • forecasting future company cash flow, NPV, IRR for pipeline projects • assisting with material & drug sourcing and device development & scale-up • mapping of regulatory landscape and appropriate FDA guidance • facilitating tech-transfer with in-licensed IP • supporting clinical trial coordination and oversight • authoring comprehensive, cross-indication scientific literature reviews • managing external market research projects with business intelligence firms For my role, I work closely with Juniper's Chief Medical Officer, Director of New Product Development, CEO, CSO and CFO. Juniper is currently investigating several new technologies, including a controlled-release bioadhesive gel, and a drug delivery device licensed from Dr. Robert Langer of the Massachusetts Institute of Technology and Dr. William Crowley of Massachusetts General Hospital and Harvard Medical School. The company plans to announce launch of several new product initiatives in the near future. From February 2015 to Present (11 months) Managing Analyst, Medical Devices @ From October 2013 to February 2015 (1 year 5 months) Senior Analyst, Medical Devices @ From August 2012 to September 2013 (1 year 2 months) Consultant, Biotechnology & Medical Devices @ From 2009 to July 2012 (3 years) Biomedical Engineering Researcher @ From 2009 to 2010 (1 year) Mathematics Teaching Assistant @ From 2006 to 2009 (3 years) NSF Biomedical Engineering Researcher @ From 2008 to 2008 (less than a year) Biomedical Engineering Researcher @ From 2007 to 2007 (less than a year) Stem Cell Institute Research Intern @ From 2007 to 2007 (less than a year) Ranch Hand @ From 2006 to 2006 (less than a year) Lifeguard @ From 2002 to 2005 (3 years)

Master of Science (M.Sc.), Biomedical Engineering @ Columbia University - Fu Foundation School of Engineering and Applied ScienceBachelor of Science (B.S.), Biomedical Engineering @ Bucknell University Rob Littlefield is skilled in: Competitive Intelligence, Strategic Partnerships, Market Research, Forecasting, Drug Delivery, Biotechnology, Medical Devices, Product Development, Market Assessments, Qualitative Research, Business Intelligence, Data Analysis, Strategy, Biomedical Engineering, Primary Research